ArticleJournal of cancer research and clinical oncology2009

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP.

Takeshi Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.